Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).
Saved in:
| Title: | Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). |
|---|---|
| Authors: | Kehmann, Linde1,2 (AUTHOR), Berres, Marie-Luise3 (AUTHOR), Gonzalez-Carmona, Maria4 (AUTHOR), Modest, Dominik P.5 (AUTHOR), Mohr, Raphael1 (AUTHOR), Wree, Alexander1 (AUTHOR), Venerito, Marino6 (AUTHOR), Strassburg, Christian4 (AUTHOR), Keitel, Verena6 (AUTHOR), Trautwein, Christian3 (AUTHOR), Luedde, Tom7 (AUTHOR), Roderburg, Christoph7 (AUTHOR) christoph.roderburg@med.uni-duesseldorf.de |
| Source: | BMC Cancer. 5/22/2023, Vol. 23 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-023-10972-6 |
